வரிசைப்படுத்துதல் தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வரிசைப்படுத்துதல் தொழில்நுட்பம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வரிசைப்படுத்துதல் தொழில்நுட்பம் Today - Breaking & Trending Today

Long Read Sequencing Market 2021-Industry Size, Growth Factors, Development Strategy|Top Leaders- TA


Search jobs
20-May-2021
Long Read Sequencing Market 2021-Industry Size, Growth Factors, Development Strategy|Top Leaders- TATAA Biocenter, FG Technologies, Roche Sequencing (A subsidiary of F. Hoffmann-La Roche Ltd), Universal Sequencing Technology (UST)
Data Bridge Market Research added recently released new research report on
Long Read Sequencing Market 2021 by Top players, Regions, Type and Application, Forecast provides a complete analysis which studies the industry coverage, current market competitive status, and market outlook. It highlights the key driving factors, constraints, opportunities, and challenges in the competitive market. The report contains facts and numbers regarding the market size, geographical landscape, and profit forecast of the global Long Read Sequencing market. The global Long Read Sequencing market report collects data about the target market such as pricing trends, customer requirements, ....

United States , Hong Kong , United Kingdom , South Africa , Saudi Arabia , South Korea , Lexogen Gmb , Biocat Gmb , Pacific Biosciences , Agilent Technologies Inc , Academic Research Institutes , Quantapore Inc , California Inc , Technology Molecule Time , Takara Bio Inc , Research Phases , Porter Five Forces Analysis , Roche Ltd , Brooks Automation Inc , Market Research , Macrogen Inc , Novogene Corporation , Illumina Inc , Thermo Fisher Scientific Inc , Data Bridge Market Research , Promega Corporation ,

Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities


Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities
March 12, 2021 05:03 ET
| Source:
Research and Markets
Research and Markets
Dublin, IRELAND
ResearchAndMarkets.com s offering.
The Global Precision Medicine Market is estimated to be USD 53.5 Bn in 2020 and is expected to reach USD 92.2 Bn by 2025 growing at a CAGR of 11.5%.
The factors such as patient s involvement in personal healthcare, development of technologies such as sequencing technologies, increasing genetic diseases, the growing demand for targeted therapies, and integration of big data healthcare companies with pharma & biotech companies are driving the market growth. The increasing population and rising cancer cases in developing countries in the APAC region like India and China are the major factors propelling the growth of the precision medicine market. The current soaring prices of drug discov ....

United States , United Kingdom , Asia Pacific , Bristol Myers Squibb , Laura Wood , Almac Group Ltd , National Institute Of Health , Omnicell Inc , Bristol Myers Squibb Company , Precision Medicine Initiative , Pharma Biotech Companies , Astellas Pharma Inc , Pfizer Inc , Ion Semiconductor Sequencing , Healthcare It Big Data Companies , Porter Five Forces Analysis , Eli Lilly Company , Office Hours Call , Laboratory Corporation Of America Holdings , Research Methodology , Roche Holding Ag , Company Profiles , Bio Rad Laboratories Inc , E St Office Hours Call , Amgen Inc , Tool Companies ,

Global Human Microbiome Therapeutics Market Report 2020: COVID-19 Pandemic has Decreased Short-term Potential Growth Opportunities


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global human microbiome therapeutics market is expected to reach a value of nearly $148.6 million in 2025, having increased at a compound annual growth rate (CAGR) of 21.9% since 2023. The market is expected to increase from $148.6 million in 2025 to $400.0 million in 2030 having increasing at growth rate of 21.9%.
Growth is forecast period is expected to drive by increase in funding, increase in prevalence of chronic diseases and technological advances. Factors that could hinder the growth of the human microbiome therapeutics market in the future include ethical issues associated with the market.
The human microbiome therapeutics market is segmented disease into infectious diseases, gastrointestinal disorders, metabolic disorders, cancers and other diseases. The infectious diseases market was the largest segment of the human microbiome therapeutics market segmented by disease, accoun ....

United States , Asia Pacific , Laura Wood , Enterome Bioscience , Custom Research , Assembly Biosciences , Investments On Development Of Cancer Microbiome Therapeutics , Office Hours Call , Microbiome Therapeutics , Second Genome Inc , Vithera Pharmaceuticals Inc , Drug Development , E St Office Hours Call , Technology Type , Rebiotix Inc , Western Europe , North America , Eastern Europe , South America , Seres Therapeutics , Vedanta Biosciences , Topics Covered , Microbiome Therapeutics Market Executive , Microbiome Therapeutics Market , Sequencing Technology , Genome Sequencing ,

Spatial Genomics & Transcriptomics Market by Technique, Product, Application and End-user


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.
Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development, and increasing investment in biopharmaceutical R&D. On the other hand, lack of awareness about these techniques in the emerging countries and the high cost of instruments are some factors limiting the market growth.
By application, the translational research accounted for the largest share of the spatial genomics & transcriptomics market ....

United States , United Kingdom , South Africa , Miltenyi Biotec , Europe Ro , Africa Romea , Latin America Latam , Immunohistochemistry Ihc , Asia Pacific Roapac , Latin America Rolatam , Asia Pacific , Immunohistochemistry Immunofluorescence , Laura Wood , Nanostring Technologies Inc , Biopharma Companies To Support Market Growth , Ultivue Inc , Translational Research , Rarecyte Inc , Biopharma Biotech Companies , Office Hours Call , Research Methodology , Research Funding , Vizgen Corp , Optical Biosystems Inc , Fluidigm Corporation , Dependence On Contract Research Organizations ,